Status:

COMPLETED

Alternate Day Micafungin: A PK Study in Pediatric Patients

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Collaborating Sponsors:

Astellas Pharma Inc

Conditions:

Fungal Infection

Eligibility:

All Genders

29-10 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to examine the pharmacokinetics of micafungin when it is given on an every other day schedule. The study will determine if every other day micafungin will provide drug exp...

Detailed Description

Disseminated fungal infection is a major cause of morbidity and mortality in immunocompromised children. Many of the drugs used for fungal prophylaxis have been associated with kidney and liver toxici...

Eligibility Criteria

Inclusion

  • Hospitalized patients who are at risk for fungal infection and require prophylaxis.
  • Age ≤ 10 years excluding neonates
  • Children must have an indwelling venous access device
  • Patients with adequate organ function (documented within 2 weeks prior to start of micafungin): creatinine \< 2 times upper limit normal; ALT, AST and total bilirubin ≤ 3 times upper limit normal

Exclusion

  • Patients who are \< 28 days old (neonates) or \> 10 years of age
  • Patients who have history of past or evidence of active fungal disease (by either radiological studies or biopsy proven) or are being treated for presumed fungal infection.
  • Patients who have history of allergy to micafungin or other echinocandin preparations, such as Caspofungin or Anidulafungin.
  • Patients who have received micafungin or other echinocandin preparations in the previous two weeks.
  • Patients receiving antifungal prophylaxis other than Fluconazole at the time of enrollment.
  • Failure to sign informed consent, or inability to undergo informed consent process.
  • Not medically advisable to obtain the specimens necessary.

Key Trial Info

Start Date :

July 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT00842504

Start Date

July 1 2007

End Date

December 1 2009

Last Update

February 16 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Alternate Day Micafungin: A PK Study in Pediatric Patients | DecenTrialz